Halozyme Therapeutics Inc(HALO)— 技術面狀態
數據截至2026-10-12 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades +4.6% vs the 50-day and +39.5% vs the 200-day average, 4.9% below the 52-week high and +81.4% off the 52-week low; a golden cross printed 70 sessions ago. Computed from daily closes.
Ranked #44 on today’s Directional Flow — Getting stronger list (scan of 2026-10-12).
移動平均線狀態
- 相對20日均線+0.2%
- 相對50日均線+4.6%
- 相對200日均線+39.5%
- 52週區間低於52週高點4.9% · 高於52週低點81.4%
- 連續走勢連續2個交易日上漲
- 均線交叉黃金交叉(70個交易日前)
- 50日均線交叉股價向上穿越50日均線(106個交易日前)
- 隨機指標%K 43.4 · %D 36.3(黃金交叉)
FAQ · from the current data · as of 2026-10-12
Quick answers
HALO目前的Closelook訊號是什麼?
Uptrend stack intact — Trades +4.6% vs the 50-day and +39.5% vs the 200-day average, 4.9% below the 52-week high and +81.4% off the 52-week low; a golden cross printed 70 sessions ago. Computed from daily closes.(截至2026-10-12;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
HALO目前是否位於50日與200日均線上方?
截至2026-10-12,Halozyme Therapeutics Inc位於50日均線上方(+4.6%),200日均線上方(+39.5%);距20日均線+0.2%。
HALO距52週高點有多遠?
截至2026-10-12,低於52週高點4.9%,高於52週低點81.4%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- PTGX Protagonist Therapeutics Incindustry
- REGN Regeneron Pharmaceuticals Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- RPRX Royalty Pharma Plcindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- NTLA Intellia Therapeutics Incindustry